139 related articles for article (PubMed ID: 9105409)
21. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
Wadler S; Goldman M; Lyver A; Wiernik PH
Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of 3'-azido-3'-deoxythymidine incorporation into DNA in human colon tumor cells.
Sharma M; Jain R; Ionescu E; Darnowski JW
Bioconjug Chem; 1995; 6(5):536-40. PubMed ID: 8974451
[TBL] [Abstract][Full Text] [Related]
24. Effect of indomethacin, aspirin, and acetaminophen on in vitro antiviral and antiproliferative activities of recombinant human interferon-alpha 2a.
Takaoki M; Yamashita Y; Koike K; Matsuda S
J Interferon Res; 1988 Dec; 8(6):727-33. PubMed ID: 3230331
[TBL] [Abstract][Full Text] [Related]
25. Effect of recombinant interferon-alpha on bleomycin-induced chromosome damage in hamster cells.
Bolzán AD; Correa MV; Bianchi MS
Mutat Res; 2002 Aug; 505(1-2):43-50. PubMed ID: 12175904
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of thymidine transport by 3'-azido-3'-deoxythymidine and its metabolites.
Zimmerman TP; Domin BA; Mahony WB
Oncol Res; 1993; 5(12):483-7. PubMed ID: 8086670
[TBL] [Abstract][Full Text] [Related]
28. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
Sommadossi JP; Carlisle R; Zhou Z
Mol Pharmacol; 1989 Jul; 36(1):9-14. PubMed ID: 2747633
[TBL] [Abstract][Full Text] [Related]
29. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
Bhalla K; Birkhofer M; Grant S; Graham G
Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
[TBL] [Abstract][Full Text] [Related]
30. Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS).
Zeidner NS; Rose LM; Mathiason-DuBard CK; Myles MH; Hill DL; Mullins JI; Hoover EA
J Acquir Immune Defic Syndr (1988); 1990; 3(8):787-96. PubMed ID: 2164083
[TBL] [Abstract][Full Text] [Related]
31. Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Chandrasekaran B; Kute TE; Duch DS
Cancer Chemother Pharmacol; 1995; 35(6):489-95. PubMed ID: 7882457
[TBL] [Abstract][Full Text] [Related]
32. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Avramis VI; Kwock R; Solorzano MM; Gomperts E
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of mammalian DNA polymerase-associated 3' to 5' exonuclease activity by 5'-monophosphates of 3'-azido-3'-deoxythymidine and 3'-amino-3'-deoxythymidine.
Bridges EG; Faraj A; Sommadossi JP
Biochem Pharmacol; 1993 Apr; 45(8):1571-6. PubMed ID: 8387298
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
[TBL] [Abstract][Full Text] [Related]
35. 3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
Weidner DA; Sommadossi JP
Mol Pharmacol; 1990 Dec; 38(6):797-804. PubMed ID: 2174502
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
37. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
Fridland A; Connelly MC; Ashmun R
Mol Pharmacol; 1990 May; 37(5):665-70. PubMed ID: 2338944
[TBL] [Abstract][Full Text] [Related]
38. Hydroxyurea enhances 3'-azido-3'-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models.
Tosi P; Visani G; Ottaviani E; Tura S; Darnowski JW
Eur J Haematol; 1994 May; 52(5):291-5. PubMed ID: 8020629
[TBL] [Abstract][Full Text] [Related]
39. Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
Ismail A; Van Groeningen CJ; Hardcastle A; Ren Q; Aherne GW; Geoffroy F; Allegra CJ; Grem JL
Mol Pharmacol; 1998 Feb; 53(2):252-61. PubMed ID: 9463483
[TBL] [Abstract][Full Text] [Related]
40. Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.
Bajetta E; Di Leo A; Zampino MG; Sertoli MR; Comella G; Barduagni M; Giannotti B; Queirolo P; Tribbia G; Bernengo MG
J Clin Oncol; 1994 Apr; 12(4):806-11. PubMed ID: 8151323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
